ArticleImmunotherapy advances2025

Intra-tumoural RAMP1+ B cells promote resistance to neoadjuvant anti-PD-1-based therapy in oesophageal squamous cell carcinoma.

Hongyu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.